Table 1.
Demographic characteristics and treatment data for individuals selected for the analysis from the LIBD, UNIBA1, UNIBA2, PNC, ABCD, and UKB cohorts
| Cohort | Group | N | Mean age ± SD in years (range) | %Male | Mean chlorpromazine equivalents ± SD in mg/day |
|---|---|---|---|---|---|
| LIBD | yNC | 200 | 22 ± 2 (18:25) | 42 | / |
| oNC | 246 | 41 ± 7 (30:56) | 47 | / | |
| ySIB | 41 | 21 ± 2 (18:25) | 68 | / | |
| oSIB | 40 | 42 ± 8 (30:60) | 41 | / | |
| oSCZ | 88 | 40 ± 8 (30:56) | 59 | 258 ± 221 (N = 54) | |
| UNIBA 1 | yNC | 356 | 22 ± 2 (18:25) | 39 | / |
| oNC | 125 | 39 ± 7 (30:60) | 62 | / | |
| ySIB | 12 | 22 ± 2 (17:25) | 30 | / | |
| oSIB | 46 | 40 ± 6 (30:59) | 41 | / | |
| oSCZ | 82 | 38 ± 6 (30:58) | 45 | 219 ± 151 (N = 54) | |
| UNIBA 2 | yNC | 127 | 22 ± 1 (17:25) | 37 | / |
| oNC | 57 | 35 ± 6 (30:59) | 63 | / | |
| yPSY | 46 | 20 ± 3 (16:25) | 47 | / | |
| oSCZ | 25 | 37 ± 6 (30:50) | 64 | 182 ± 96 (N = 20) | |
| PNC | cNC | 90 | 11 ± 2 (8:14) | 47 | / |
| cPSY | 44 | 12 ± 1 (9:14) | 59 | / | |
| yNC | 74 | 17 ± 2 (15:23) | 55 | / | |
| yPSY | 79 | 17 ± 2 (15:23) | 34 | / | |
| ABCD | cNC | 3,636 | 9.9 ± 1 (9:11) | 47 | / |
| cSIB/FHR | 62 | 9.9 ± 1 (9:11) | 53 | / | |
| cPSY | 1,238 | 9.8 ± 1 (9:11) | 24 | / | |
| UKB | oNC | 2,520 | 53 ± 6 (40:60) | 47 | / |